# Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

> **NCT07125391** · PHASE2 · RECRUITING · sponsor: **Bai-Rong Xia** · enrollment: 40 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Cohort A

## Key facts

- **NCT ID:** NCT07125391
- **Lead sponsor:** Bai-Rong Xia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-08-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07125391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07125391, "Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07125391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*